Tag: evaluating

Clinical Trials & Research

AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology

Executive Overview The landscape of immuno-oncology has long been defined by the pursuit of combination therapies and multi-targeted biologic agents...

23 Aug 2026

Clinical Trials & Research

Akeso Doses First Patient in Landmark Phase II Trial Evaluating Novel AK146D1 and Ivonescimab Combination for Advanced Breast Cancer

Executive Overview In a significant milestone for next-generation oncology drug development, biopharmaceutical innovator Akeso has announced the successful dosing of...

10 Aug 2026

Hematology & Blood Research

Novel Insights into Cellular Energy: Evaluating Pyruvate Kinase Activator Mitapivat (AG-348) in Healthy and Sickle Cell Disease Red Blood Cells

Executive Overview Red blood cells (RBCs) rely entirely on glycolysis to sustain their structural integrity, membrane flexibility, and essential physiological...

7 Jul 2026